Developer docs
API playgroundTry for free, no card

Search company profiles

Rune Labs

Full company profile

uuid00008yf

Namestring
Rune Labs
Legal namestring
Rune Labs, Inc.
Websiteurl
runelabs.io
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Rune Labs is a San Francisco-based software and data analytics company founded in 2018 that builds a precision neurology platform centered on Parkinson's disease. Its core product is StrivePD, a care delivery ecosystem comprising a patient-facing iOS application paired with Apple Watch that uses FDA 510(k)-cleared algorithms to continuously monitor tremor and dyskinesia, paired with clinician dashboards summarizing multi-source patient data. StriveStudy, launched in 2023, is a GCP-compliant cloud-based clinical trial platform providing data collection, enriched patient recruitment, and synthetic control cohorts for pharmaceutical and biotechnology customers developing precision neurology therapies. The underlying Rune Labs Data Infrastructure integrates time-series data from wearables (Apple Watch via HealthKit), neuromodulation devices (Medtronic BrainSense), and patient-reported outcomes into a HIPAA-compliant, zero-trust pipeline accessible through a Stream API and Python SDK.

The company monetizes through subscription-based SaaS across four streams: enterprise StrivePD deployments with healthcare systems, StriveStudy contracts with life sciences companies, real-world evidence offerings to pharma and biotech, and commercial channel solutions for therapy manufacturers. Go-to-market is multi-modal, combining direct-to-consumer acquisition via the iOS App Store for patients, field sales to life sciences enterprises, clinician-focused sales to healthcare provider networks (anchored by Kaiser Permanente), and developer relations through open APIs and SDKs. The company also operates a wholly-owned Portuguese subsidiary established in 2022 to serve European markets. Rune Labs has raised approximately $53 million across seed, Series A, and strategic rounds, holds regulatory clearances including FDA 510(k) and HIPAA/GDPR/CCPA compliance, and is led by CEO Amy Gordon Franzen (appointed January 2026 from Tempus) alongside founder Brian Pepin.

Short descriptiontext

Rune Labs is a precision neurology software and data platform offering the StrivePD care delivery ecosystem for Parkinson's patients and the StriveStudy clinical trial platform for life sciences, built on FDA-cleared Apple Watch-based symptom monitoring and what it claims is the world's largest Parkinson's dataset.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
precision neurology software, Parkinson's disease monitoring, clinical trial platform, brain data analytics, digital biomarker platform
Industry1 code
PRIMARYHLALAFAJ
Neurology RPM (epilepsy, Parkinson’s, MS monitoring)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
NAICS code1 code
  • Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services51821
SIC code1 code
  • Services-Computer Programming Services7371
Product category
Precision Neurology Software
Social media profiles2 records
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model4 records
1StrivePD Care Delivery Platform
TypeSubscription Recurring
Description

Subscription-based SaaS revenue from healthcare providers and patients using the StrivePD ecosystem for Parkinson disease management. Includes symptom tracking, medication reminders, clinician dashboards, and data sharing capabilities.

2StriveStudy Clinical Trial Platform
TypeSubscription Recurring
Description

GCP-compliant cloud-based platform providing clinical trial solutions including data collection, enriched recruitment, baseline/long-term data collection, and synthetic control cohorts for life sciences companies.

runelabs.io
3Real-World Evidence Solutions
TypeSubscription Recurring
Description

Revenue from pharmaceutical and biotech companies leveraging Rune's real-world datasets for post-marketing studies, comparative effectiveness research, and patient segmentation.

runelabs.io
4Commercial Channel Solutions
TypeSubscription Recurring
Description

Custom solutions for therapy manufacturers to increase awareness, enable onboarding, and drive treatment effectiveness through tailored clinician workflows and data-enriched medication management.

runelabs.io
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Pricing details2 tiers
1StrivePD patient-facing app - likely free or freemium tier with premium features
ModelFreemiumBilling cadenceMonthly
Notes

Basic symptom tracking and medication reminders available; specific premium tier pricing not publicly disclosed

2Enterprise life sciences platform (StriveStudy) - custom enterprise pricing
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based pricing for clinical trial support, real-world evidence, and commercial channel solutions. Pricing varies by scope, data volume, and support requirements.

runelabs.io
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1StrivePD
Description

Care delivery ecosystem for Parkinson's disease enabling patients to manage symptoms via Apple Watch and patient app, providing clinicians with curated dashboards and connecting patients to clinical trials

runelabs.io
+2 more records
Core offering1 text field

Rune Labs builds a precision neurology software and data platform that combines wearable (Apple Watch) and neural implant data into a HIPAA-compliant cloud infrastructure. It sells the StrivePD care delivery ecosystem to clinicians and patients for Parkinson's symptom management, the StriveStudy clinical trial platform and real-world evidence solutions to life sciences companies, and the underlying Rune Labs Data Infrastructure with a Stream API to therapy developers and researchers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Nearly 50% reduction in ER visits for Parkinson's patients in Kaiser Permanente program
+2 more records
Product overview1 text field

Rune Labs is a precision neurology software and data analytics company with a multi-product portfolio centered on Parkinson's disease management and therapy development. The core offering is StrivePD, a care delivery ecosystem comprising a patient-facing mobile app that connects to Apple Watch for continuous symptom monitoring and a clinician portal with curated patient dashboards. StrivePD Guardian is an AI-powered companion add-on built on Anthropic's Claude that provides conversational symptom analysis and personalized guidance. For life sciences partners, StriveStudy provides a GCP-compliant clinical trial platform supporting data collection, enriched recruitment, and real-world evidence generation. The underlying Rune Labs Data Infrastructure platform offers a HIPAA-compliant software-as-a-service solution with a Stream API for accessing aggregated neurological data from wearables and neuromodulation devices.

Product and service4 records
1StrivePD
CategoryCare delivery platform
Description

Care delivery ecosystem for Parkinson's disease that enables patients to manage symptoms through an Apple Watch-paired app and provides clinicians with curated dashboards summarizing multi-source patient data, plus connections to clinical trials.

2StriveStudy
CategoryClinical trial platform
Description

GCP-compliant, cloud-based clinical trial platform offering wrap-around solutions for data collection, enriched recruitment, synthetic control cohorts, and longitudinal multi-modal data management for life sciences therapy development.

3Rune Labs Data Infrastructure
CategoryData infrastructure platform
Description

SaaS data infrastructure platform for neuromodulation and brain therapies that integrates time-series electrophysiology, neuromodulation device, and wearable data, featuring an encrypted HIPAA-compliant pipeline and collaboration tools for industry and academic research.

4Rune Labs Stream API
CategoryDeveloper API
Description

HTTP API with V1 and V2 endpoints, Python SDK, and Jupyter Notebook tutorials for querying time-series data derived from data uploaded to the Rune Platform, including stream availability, daily aggregates, and aggregate window queries.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic research partnership with UCSF (University of California, San Francisco) for precision neurology research. Location near UCSF neurosurgery campus enables close collaboration with Bay Area clinicians.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic partnership for neuroscience research collaborations, particularly in brain data analysis and neuromodulation.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic research partnership for neuroscience and neurological disorder research.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic partnership for neuroscience research collaborations.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration using Rune Labs clinical trial platform to better characterize Parkinson's disease state in cell therapy trials. Rune provides data infrastructure and patient monitoring capabilities.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration to deeply characterize symptom activity in Parkinson's disease for upcoming trial-ready cohort screening study.

Strategic tierCoreTypeTechnology or Integration
Description

Partnership to evaluate use of Medtronic BrainSense data in Rune's software for precision neurology. Integration of deep brain stimulation data with Rune's platform.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership to identify biomarkers of Multiple Sclerosis lesions using AI platform to analyze patient neurophysiological data.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical program demonstrating nearly 50% reduction in ER visits for Parkinson's patients using StrivePD. Evidence-based partnership showcasing real-world outcomes.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Joint clinical program to correlate genetic and digital biomarkers for Parkinson's disease. First program of its kind combining genetic and wearable data.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Akili Interactive is a prescription digital therapeutics company that has secured FDA clearance for cognition-focused digital treatments. It is comparable to Rune Labs as a regulated, evidence-based digital therapeutic platform targeting neurological conditions with a software-first delivery model.

TypeDirect peer
Description

Click Therapeutics develops prescription digital therapeutics and combines them with pharma partnerships for clinical development and commercialization. It is comparable to Rune Labs in combining a regulated patient-facing digital product with a clinical trial and life sciences commercialization motion.

TypeDirect peer
Description

Empatica builds FDA-cleared wearable sensors and digital biomarkers for neurological conditions including epilepsy and Parkinson's. It is comparable to Rune Labs in using regulated wearable data capture and digital biomarkers as the foundation for both patient care and clinical research offerings.

TypeEmerging player
Description

NeuraLight is an AI-driven digital biomarker company focused on neurological disorders, using computer vision and oculometric data to quantify neurological disease progression. It is comparable to Rune Labs as a digital biomarker platform serving pharma CNS trials and neurology drug development.

TypeEmerging player
Description

Altoida develops digital cognitive and neurological assessments using smartphone- and AR-based tasks to detect early signs of neurological disease. It is comparable to Rune Labs in leveraging consumer-grade devices and AI to generate clinical-grade neurological endpoints for care and clinical research.

TypeEmerging player
Description

Linus Health applies AI-driven digital cognitive assessment to enable early detection and monitoring of neurological conditions such as Alzheimer's and dementia. It is comparable to Rune Labs in combining patient-facing digital tools, clinician dashboards, and pharma/life sciences partnerships in neurology.

TypeBroad incumbent
Description

Medtronic is the largest neuromodulation and deep brain stimulation device manufacturer and a current Rune Labs partner (BrainSense). It is comparable both as a data and software counterpart in DBS-linked Parkinson's care and as a potential competitor if it internalizes similar precision neurology software capabilities.

TypeBroad incumbent
Description

Boston Scientific operates a major neuromodulation business including DBS and Vercise systems that generate the same kind of device-derived neural data Rune Labs integrates. It is comparable as a broad incumbent in the same precision neurology ecosystem that could partner with or compete against Rune's platform.

TypeBroad incumbent
Description

Abbott's Neuromodulation division (formerly St. Jude Medical) develops DBS and other neurostimulation devices and increasingly invests in connected, data-driven therapy management software. It is comparable to Rune Labs as a broad incumbent neuromodulation player whose device data and software strategy overlap with Rune's platform.

TypeBroad incumbent
Description

Verily, Alphabet's health sciences subsidiary, builds data platforms, wearable-derived biomarkers, and clinical research infrastructure including programs in Parkinson's and other neurological conditions. It is comparable to Rune Labs as a well-capitalized digital health platform combining wearable data, AI, and clinical research partnerships in neurology.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration6 records

Each record includes

Title, Type, Description, Source

AI capability8 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors8 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Rune Labs

Precision Neurology Softwarerunelabs.io

Rune Labs is a precision neurology software and data platform offering the StrivePD care delivery ecosystem for Parkinson's patients and the StriveStudy clinical trial platform for life sciences, built on FDA-cleared Apple Watch-based symptom monitoring and what it claims is the world's largest Parkinson's dataset.

What Rune Labs does

Rune Labs is a San Francisco-based software and data analytics company founded in 2018 that builds a precision neurology platform centered on Parkinson's disease. Its core product is StrivePD, a care delivery ecosystem comprising a patient-facing iOS application paired with Apple Watch that uses FDA 510(k)-cleared algorithms to continuously monitor tremor and dyskinesia, paired with clinician dashboards summarizing multi-source patient data. StriveStudy, launched in 2023, is a GCP-compliant cloud-based clinical trial platform providing data collection, enriched patient recruitment, and synthetic control cohorts for pharmaceutical and biotechnology customers developing precision neurology therapies. The underlying Rune Labs Data Infrastructure integrates time-series data from wearables (Apple Watch via HealthKit), neuromodulation devices (Medtronic BrainSense), and patient-reported outcomes into a HIPAA-compliant, zero-trust pipeline accessible through a Stream API and Python SDK.

The company monetizes through subscription-based SaaS across four streams: enterprise StrivePD deployments with healthcare systems, StriveStudy contracts with life sciences companies, real-world evidence offerings to pharma and biotech, and commercial channel solutions for therapy manufacturers. Go-to-market is multi-modal, combining direct-to-consumer acquisition via the iOS App Store for patients, field sales to life sciences enterprises, clinician-focused sales to healthcare provider networks (anchored by Kaiser Permanente), and developer relations through open APIs and SDKs. The company also operates a wholly-owned Portuguese subsidiary established in 2022 to serve European markets. Rune Labs has raised approximately $53 million across seed, Series A, and strategic rounds, holds regulatory clearances including FDA 510(k) and HIPAA/GDPR/CCPA compliance, and is led by CEO Amy Gordon Franzen (appointed January 2026 from Tempus) alongside founder Brian Pepin.

Rune Labs firmographics

Firmographics
Name
Rune Labs
Legal name
Rune Labs, Inc.
Website
https://runelabs.io
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
11–50 employees
Short description
Rune Labs is a precision neurology software and data platform offering the StrivePD care delivery ecosystem for Parkinson's patients and the StriveStudy clinical trial platform for life sciences, built on FDA-cleared Apple Watch-based symptom monitoring and what it claims is the world's largest Parkinson's dataset.
Ownership category
akta.pro rank

Rune Labs industry classification

Industry
Product category
Precision Neurology Software
NAICS
Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (51821)
SIC
Services-Computer Programming Services (7371)
akta.pro industry
PRIMARYHLALAFAJ
Neurology RPM (epilepsy, Parkinson’s, MS monitoring)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms

Keywords

  • Precision neurology software
  • Parkinson's disease monitoring
  • Clinical trial platform
  • Brain data analytics
  • Digital biomarker platform

Where Rune Labs is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Rune Labs business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. StrivePD Care Delivery Platform: Subscription-based SaaS revenue from healthcare providers and patients using the StrivePD ecosystem for Parkinson disease management. Includes symptom tracking, medication reminders, clinician dashboards, and data sharing capabilities.
  2. StriveStudy Clinical Trial Platform: GCP-compliant cloud-based platform providing clinical trial solutions including data collection, enriched recruitment, baseline/long-term data collection, and synthetic control cohorts for life sciences companies.
  3. Real-World Evidence Solutions: Revenue from pharmaceutical and biotech companies leveraging Rune's real-world datasets for post-marketing studies, comparative effectiveness research, and patient segmentation.
  4. Commercial Channel Solutions: Custom solutions for therapy manufacturers to increase awareness, enable onboarding, and drive treatment effectiveness through tailored clinician workflows and data-enriched medication management.

Pricing tiers

ModelBillingPrice
FreemiumMonthlyStrivePD patient-facing app - likely free or freemium tier with premium features
SubscriptionAnnualEnterprise life sciences platform (StriveStudy) - custom enterprise pricing

Go-to-market motion4 records

Distribution channels5 records

Marketing channels6 records

Rune Labs product offering

Product offering

Core offering

Rune Labs builds a precision neurology software and data platform that combines wearable (Apple Watch) and neural implant data into a HIPAA-compliant cloud infrastructure. It sells the StrivePD care delivery ecosystem to clinicians and patients for Parkinson's symptom management, the StriveStudy clinical trial platform and real-world evidence solutions to life sciences companies, and the underlying Rune Labs Data Infrastructure with a Stream API to therapy developers and researchers.

Product overview

Rune Labs is a precision neurology software and data analytics company with a multi-product portfolio centered on Parkinson's disease management and therapy development. The core offering is StrivePD, a care delivery ecosystem comprising a patient-facing mobile app that connects to Apple Watch for continuous symptom monitoring and a clinician portal with curated patient dashboards. StrivePD Guardian is an AI-powered companion add-on built on Anthropic's Claude that provides conversational symptom analysis and personalized guidance. For life sciences partners, StriveStudy provides a GCP-compliant clinical trial platform supporting data collection, enriched recruitment, and real-world evidence generation. The underlying Rune Labs Data Infrastructure platform offers a HIPAA-compliant software-as-a-service solution with a Stream API for accessing aggregated neurological data from wearables and neuromodulation devices.

Differentiator

Problem solved

Functional benefit

Brands

  • StrivePD: Care delivery ecosystem for Parkinson's disease enabling patients to manage symptoms via Apple Watch and patient app, providing clinicians with curated dashboards and connecting patients to clinical trials
  • StriveStudy
  • StrivePD Guardian

Products and services

  • StrivePD Care delivery ecosystem for Parkinson's disease that enables patients to manage symptoms through an Apple Watch-paired app and provides clinicians with curated dashboards summarizing multi-source patient data, plus connections to clinical trials.
  • StriveStudy GCP-compliant, cloud-based clinical trial platform offering wrap-around solutions for data collection, enriched recruitment, synthetic control cohorts, and longitudinal multi-modal data management for life sciences therapy development.
  • Rune Labs Data Infrastructure SaaS data infrastructure platform for neuromodulation and brain therapies that integrates time-series electrophysiology, neuromodulation device, and wearable data, featuring an encrypted HIPAA-compliant pipeline and collaboration tools for industry and academic research.
  • Rune Labs Stream API HTTP API with V1 and V2 endpoints, Python SDK, and Jupyter Notebook tutorials for querying time-series data derived from data uploaded to the Rune Platform, including stream availability, daily aggregates, and aggregate window queries.

Quantifiable outcome

  • Nearly 50% reduction in ER visits for Parkinson's patients in Kaiser Permanente program
  • +2 more outcomes

Companies that use Rune Labs

Customer profile

Named customers7 records

Segments5 records

Ideal customer profiles4 records

Rune Labs technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration6 records

AI capability8 records

Feature7 records

Rune Labs partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core and minor.

  • UCSFcoreStrategic or Co-development PartnerAcademic research partnership with UCSF (University of California, San Francisco) for precision neurology research. Location near UCSF neurosurgery campus enables close collaboration with Bay Area clinicians.
  • Mount SinaicoreStrategic or Co-development PartnerAcademic partnership for neuroscience research collaborations, particularly in brain data analysis and neuromodulation.
  • Baylor UniversityminorStrategic or Co-development PartnerAcademic research partnership for neuroscience and neurological disorder research.
  • Brown UniversityminorStrategic or Co-development PartnerAcademic partnership for neuroscience research collaborations.
  • BlueRock TherapeuticscoreStrategic or Co-development PartnerCollaboration using Rune Labs clinical trial platform to better characterize Parkinson's disease state in cell therapy trials. Rune provides data infrastructure and patient monitoring capabilities.
  • Aspen NeurosciencecoreStrategic or Co-development PartnerCollaboration to deeply characterize symptom activity in Parkinson's disease for upcoming trial-ready cohort screening study.
  • MedtroniccoreTechnology or IntegrationPartnership to evaluate use of Medtronic BrainSense data in Rune's software for precision neurology. Integration of deep brain stimulation data with Rune's platform.
  • Coastal Research InstituteminorStrategic or Co-development PartnerPartnership to identify biomarkers of Multiple Sclerosis lesions using AI platform to analyze patient neurophysiological data.
  • Kaiser PermanentecoreStrategic or Co-development PartnerClinical program demonstrating nearly 50% reduction in ER visits for Parkinson's patients using StrivePD. Evidence-based partnership showcasing real-world outcomes.
  • Parkinson's FoundationcoreStrategic or Co-development PartnerJoint clinical program to correlate genetic and digital biomarkers for Parkinson's disease. First program of its kind combining genetic and wearable data.

Scale indicators8 records

Recent moves7 records

Expansion highlights6 records

Rune Labs competitors and assessment

Company assessment

Direct peers

  • Akili Interactive: Akili Interactive is a prescription digital therapeutics company that has secured FDA clearance for cognition-focused digital treatments. It is comparable to Rune Labs as a regulated, evidence-based digital therapeutic platform targeting neurological conditions with a software-first delivery model.
  • Click Therapeutics: Click Therapeutics develops prescription digital therapeutics and combines them with pharma partnerships for clinical development and commercialization. It is comparable to Rune Labs in combining a regulated patient-facing digital product with a clinical trial and life sciences commercialization motion.
  • Empatica: Empatica builds FDA-cleared wearable sensors and digital biomarkers for neurological conditions including epilepsy and Parkinson's. It is comparable to Rune Labs in using regulated wearable data capture and digital biomarkers as the foundation for both patient care and clinical research offerings.

Emerging players

  • NeuraLight: NeuraLight is an AI-driven digital biomarker company focused on neurological disorders, using computer vision and oculometric data to quantify neurological disease progression. It is comparable to Rune Labs as a digital biomarker platform serving pharma CNS trials and neurology drug development.
  • Altoida: Altoida develops digital cognitive and neurological assessments using smartphone- and AR-based tasks to detect early signs of neurological disease. It is comparable to Rune Labs in leveraging consumer-grade devices and AI to generate clinical-grade neurological endpoints for care and clinical research.
  • Linus Health: Linus Health applies AI-driven digital cognitive assessment to enable early detection and monitoring of neurological conditions such as Alzheimer's and dementia. It is comparable to Rune Labs in combining patient-facing digital tools, clinician dashboards, and pharma/life sciences partnerships in neurology.

Broad incumbents

  • Medtronic: Medtronic is the largest neuromodulation and deep brain stimulation device manufacturer and a current Rune Labs partner (BrainSense). It is comparable both as a data and software counterpart in DBS-linked Parkinson's care and as a potential competitor if it internalizes similar precision neurology software capabilities.
  • Boston Scientific: Boston Scientific operates a major neuromodulation business including DBS and Vercise systems that generate the same kind of device-derived neural data Rune Labs integrates. It is comparable as a broad incumbent in the same precision neurology ecosystem that could partner with or compete against Rune's platform.
  • Abbott: Abbott's Neuromodulation division (formerly St. Jude Medical) develops DBS and other neurostimulation devices and increasingly invests in connected, data-driven therapy management software. It is comparable to Rune Labs as a broad incumbent neuromodulation player whose device data and software strategy overlap with Rune's platform.
  • Verily (Alphabet): Verily, Alphabet's health sciences subsidiary, builds data platforms, wearable-derived biomarkers, and clinical research infrastructure including programs in Parkinson's and other neurological conditions. It is comparable to Rune Labs as a well-capitalized digital health platform combining wearable data, AI, and clinical research partnerships in neurology.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Rune Labs social profiles

Digital presence

Rune Labs compliance and trust

Trust signal

Compliance6 records

Rune Labs financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Rune Labs leadership team

Management profile

Number of profiles

Profiles8 records

Rune Labs subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Rune Labs funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Rune Labs M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rune Labs

What does Rune Labs do?

Rune Labs builds a precision neurology software and data platform that combines wearable (Apple Watch) and neural implant data into a HIPAA-compliant cloud infrastructure. It sells the StrivePD care delivery ecosystem to clinicians and patients for Parkinson's symptom management, the StriveStudy clinical trial platform and real-world evidence solutions to life sciences companies, and the underlying Rune Labs Data Infrastructure with a Stream API to therapy developers and researchers.

Is Rune Labs a public or private company?

Rune Labs is a private company. It is classified as venture growth investor backed and is currently operating.

When was Rune Labs founded?

Rune Labs was founded in 2018. It employs 11 to 50 people.

Where is Rune Labs based?

Rune Labs is headquartered in San Francisco, United States, in the North America region.

How does Rune Labs make money?

Four revenue lines are on record. StrivePD Care Delivery Platform is the primary driver. The others are striveStudy Clinical Trial Platform, real-World Evidence Solutions and commercial Channel Solutions.

Who are Rune Labs's main competitors?

Direct peers on record are Akili Interactive, Click Therapeutics and Empatica. Emerging players are NeuraLight, Altoida and Linus Health. Broad incumbents are Medtronic, Boston Scientific, Abbott and Verily (Alphabet).

Does Rune Labs have an API?

Yes. Rune Labs offers a V2 Stream API (HTTP API) and V1 Stream API for querying timeseries data derived from data uploaded to the Rune Platform. The V2 API introduces new concepts for organizing, storing, and accessing data. It supports querying single and multiple streams, stream availability, daily aggregates, and aggregate windows. Authentication uses access tokens (recommended) or client keys. The API returns data in CSV or JSON format with timestamps in Unix or ISO format. Supports timezone-aware windowing for non-UTC timezones. A Python SDK is available at runeq.readthedocs.io with Jupyter Notebook tutorials on GitHub. Developer documentation is at docs.runelabs.io.

What industry is Rune Labs in?

Rune Labs's product category is Precision Neurology Software. Its primary akta.pro industry code is HLALAFAJ, Neurology RPM (epilepsy, Parkinson’s, MS monitoring). Its NAICS code is 51821 and its SIC code is 7371.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Neurology liveStrivePD: Revolutionizing Parkinson Disease Care Through Data and PersonalizationRune Labs developed StrivePD, a software application designed to help Parkinson disease patients track symptoms, medication use, and patient-reported outcomes through an iPhone and Apple Watch interface. The platform collects actionable data to optimize personalized care strategies and supports clinical trials by providing real-world objective data to biopharma partners. Currently used by over 10,000 users, the app aims to improve communication between patients and clinicians while reducing hospitalizations through ongoing pilot programs.ParkinsonsnewstodayRune Labs launches AI tool for Parkinson’s symptom trackingRune Labs has launched StrivePD Guardian, an AI-powered companion tool for people with Parkinson's disease that pairs with an Apple Watch to track symptoms and provide personalized guidance on medications, daily activities, and care. The system uses FDA-cleared algorithms and real-world clinical data to interpret symptom fluctuations such as "off times" and dyskinesia, offering a conversational interface trained on continuous wearable datasets. StrivePD Guardian is available as an upgrade within the existing StrivePD app, which allows users to manually log symptoms, set medication reminders, and share data with care teams.HIT ConsultantRune Labs Launches StrivePD Guardian, an AI Companion for Parkinson’s Disease Powered by ClaudeRune Labs has launched StrivePD Guardian, an AI-powered companion app for Parkinson's disease patients that uses Anthropic's Claude AI to provide continuous, real-time support through specialized sub-agents including a Medication Assistant, Symptom Expert, PD Coach, and Data Visualizer. The platform analyzes wearable data and patient-journaled entries to generate clinically actionable reports for physicians, addressing the gap between infrequent specialist appointments. It is now available on the App Store for patients, with partner programs available for providers and payers.Business Wire BlogRune Labs Launches Parkinson’s AI Companion Trained on the World's Largest Parkinson's DatasetRune Labs announced the launch of StrivePD Guardian, an AI-powered companion for Parkinson's disease patients built on the company's proprietary dataset of millions of hours of wearable data and FDA-cleared symptom algorithms. The platform, powered by Anthropic's Claude, provides personalized, real-time guidance on symptoms, medications, and care goals through specialized agents including Medication Assistant, Symptom Expert, and PD Coach. StrivePD Guardian is now available for download from the App Store, with existing StrivePD users able to upgrade within the app.Investing.comMindMaze names Zach Henderson as chief executive officer By Investing.comMindMaze Therapeutics Holding SA appointed Zach Henderson as chief executive officer, with over 30 years of healthcare technology experience, most recently serving as chief commercial officer at Rune Labs and previously as CEO at PKG Health. The Geneva-based neurotherapeutic platform company, valued at $88.1 million with profitability over the trailing twelve months, is positioning Henderson to lead its expansion into the US market and digitize neurorestoration care across clinical and home settings. Alexandre Capet was simultaneously appointed as chief operating and strategy officer.The Globe and MailMindMaze Therapeutics Appoints HealthTech Veteran Zach Henderson as CEO to Accelerate Global Commercial ScaleMindMaze Therapeutics Holding SA announced the appointment of Zach Henderson as Chief Executive Officer, effective immediately, to lead the company's next phase of commercial growth. Henderson brings over 30 years of healthcare technology experience, most recently serving as Chief Commercial Officer at Rune Labs and previously as CEO of PKG Health, with a focus on scaling AI-driven solutions for chronic neurological conditions. The company stated this leadership transition is timed to accelerate U.S. market expansion of its FDA-cleared neurorestorative platform amid a widening global shortage of neurologists and specialized therapists.STATStartups supporting Parkinson’s care pick up new investments and key hospital partnershipsMultiple startups focused on Parkinson's disease symptom monitoring are attracting investment and hospital partnerships. Kneu Health, an Oxford University spinout, announced $5.6 million in new funding for its smartphone app platform that tracks movement, speech, and cognitive changes, while Rune Labs raised an additional $11 million bringing its total to $57 million for its Apple Watch-based tracking technology. Additionally, wearable device developer Empatica acquired PKG Health, another Parkinson's tracking technology maker, as the sector gains momentum driven by the need for better symptom monitoring beyond subjective in-person assessments.GlobeNewswireDigital Health In Neurology Market to Surpass Valuation of US$ 229.5 Billion By 2033 | Astute AnalyticaThe global digital health in neurology market is projected to grow from US$ 38.9 billion in 2024 to US$ 229.5 billion by 2033, driven by innovations like digital therapeutics, AI diagnostics, and virtual care platforms. Companies such as Akili, Rune Labs, and Blackrock Neurotech are actively developing technologies, with significant advancements in AI diagnostics, wearable devices, and telemedicine.TmcnetRune Labs Launches GenAI Clinical Support to Accelerate Care Management for Parkinson's Patients and CliniciansRune Labs launched StrivePD-AI, a GenAI clinical support tool for Parkinson's patients and clinicians, providing monthly disease progression reports and personalized coaching. The reports combine patient data with Anthropic's Claude 3.5 Sonnet and are now generally available to all users, with advanced features tied to insurers or providers.